1. Home
  2. HBB vs SWKH Comparison

HBB vs SWKH Comparison

Compare HBB & SWKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hamilton Beach Brands Holding Company

HBB

Hamilton Beach Brands Holding Company

HOLD

Current Price

$17.99

Market Cap

236.4M

ML Signal

HOLD

Logo SWK Holdings Corporation

SWKH

SWK Holdings Corporation

HOLD

Current Price

$16.80

Market Cap

198.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBB
SWKH
Founded
1904
1996
Country
United States
United States
Employees
N/A
9
Industry
Home Furnishings
Diversified Financial Services
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
236.4M
198.4M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
HBB
SWKH
Price
$17.99
$16.80
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$18.00
AVG Volume (30 Days)
22.6K
7.8K
Earning Date
04-29-2026
04-06-2026
Dividend Yield
2.92%
N/A
EPS Growth
N/A
N/A
EPS
1.95
N/A
Revenue
$606,852,000.00
N/A
Revenue This Year
N/A
$52.93
Revenue Next Year
N/A
N/A
P/E Ratio
$8.36
$9.18
Revenue Growth
N/A
N/A
52 Week Low
$12.72
$13.00
52 Week High
$20.75
$18.66

Technical Indicators

Market Signals
Indicator
HBB
SWKH
Relative Strength Index (RSI) 53.44 47.06
Support Level $17.95 $16.65
Resistance Level $20.33 $17.08
Average True Range (ATR) 0.89 0.29
MACD 0.03 0.01
Stochastic Oscillator 69.12 55.79

Price Performance

Historical Comparison
HBB
SWKH

About HBB Hamilton Beach Brands Holding Company

Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels. It has two operating segments Home and Commercial Products and Health.

About SWKH SWK Holdings Corporation

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

Share on Social Networks: